Estrategias Combinadas en Inmunoterapia Traslacional
ITC
University of Colorado Cancer Center
Aurora, Estados UnidosPublications en collaboration avec des chercheurs de University of Colorado Cancer Center (1)
2021
-
OX40 agonist BMS-986178 alone or in combination with nivolumab and/or ipilimumab in patients with advanced solid tumors
Clinical Cancer Research, Vol. 27, Núm. 2, pp. 460-472